Fubiao Kang

977 total citations
26 papers, 782 citations indexed

About

Fubiao Kang is a scholar working on Immunology, Molecular Biology and Epidemiology. According to data from OpenAlex, Fubiao Kang has authored 26 papers receiving a total of 782 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Immunology, 8 papers in Molecular Biology and 8 papers in Epidemiology. Recurrent topics in Fubiao Kang's work include Cancer Immunotherapy and Biomarkers (6 papers), Hepatitis B Virus Studies (6 papers) and HIV Research and Treatment (5 papers). Fubiao Kang is often cited by papers focused on Cancer Immunotherapy and Biomarkers (6 papers), Hepatitis B Virus Studies (6 papers) and HIV Research and Treatment (5 papers). Fubiao Kang collaborates with scholars based in China, Germany and United States. Fubiao Kang's co-authors include Dianxing Sun, Baoen Shan, Ling Wang, Dong Li, Haijun Li, Juan Wang, Wang Ling, Ling Wang, Ling Wang and Yingze Zhang and has published in prestigious journals such as PLoS ONE, International Journal of Cancer and European Journal of Immunology.

In The Last Decade

Fubiao Kang

25 papers receiving 778 citations

Peers

Fubiao Kang
Pierre Tonnerre France
Baoyun Fu China
Yiling Xu United States
Ben Zhao China
Neru Munshi United States
Christoph M. Ahlers United States
Leal Oburoglu Sweden
Meng Zhuo China
Minghua Zhu China
Mitsuru Sakakibara Japan
Pierre Tonnerre France
Fubiao Kang
Citations per year, relative to Fubiao Kang Fubiao Kang (= 1×) peers Pierre Tonnerre

Countries citing papers authored by Fubiao Kang

Since Specialization
Citations

This map shows the geographic impact of Fubiao Kang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fubiao Kang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fubiao Kang more than expected).

Fields of papers citing papers by Fubiao Kang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fubiao Kang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fubiao Kang. The network helps show where Fubiao Kang may publish in the future.

Co-authorship network of co-authors of Fubiao Kang

This figure shows the co-authorship network connecting the top 25 collaborators of Fubiao Kang. A scholar is included among the top collaborators of Fubiao Kang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fubiao Kang. Fubiao Kang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kang, Fubiao, et al.. (2022). The intriguing roles of Siglec family members in the tumor microenvironment. Biomarker Research. 10(1). 22–22. 26 indexed citations
2.
Kang, Fubiao, Wei Chen, Ling Wang, & Yingze Zhang. (2020). The diverse functions of Siglec-15 in bone remodeling and antitumor responses. Pharmacological Research. 155. 104728–104728. 33 indexed citations
3.
Wang, Ling, Guochuan Zhang, Fubiao Kang, Long Zhang, & Yingze Zhang. (2019). hsa_circ0021347 as a Potential Target Regulated by B7-H3 in Modulating the Malignant Characteristics of Osteosarcoma. BioMed Research International. 2019. 1–11. 12 indexed citations
4.
Wang, Ling, et al.. (2018). Clinical significance of serum soluble B7-H3 in patients with osteosarcoma. Cancer Cell International. 18(1). 115–115. 22 indexed citations
5.
Wang, Ling, Fubiao Kang, Juan Wang, Chao Yang, & Dongwei He. (2018). Downregulation of miR-205 contributes to epithelial–mesenchymal transition and invasion in triple-negative breast cancer by targeting HMGB1–RAGE signaling pathway. Anti-Cancer Drugs. 30(3). 225–232. 47 indexed citations
6.
Wang, Ling, et al.. (2018). B7-H4 overexpression contributes to poor prognosis and drug-resistance in triple-negative breast cancer. Cancer Cell International. 18(1). 100–100. 36 indexed citations
7.
Kang, Fubiao, Ling Wang, & Dianxing Sun. (2017). Hepatitis B virus infection in an HBsAb-positive lymphoma patient who received chemotherapy. Medicine. 96(44). e8518–e8518. 5 indexed citations
8.
Kang, Fubiao, et al.. (2017). B7-H4 overexpression is essential for early hepatocellular carcinoma progression and recurrence. Oncotarget. 8(46). 80878–80888. 12 indexed citations
9.
Li, Baosheng, Xin Cheng, Haijun Li, et al.. (2016). Suppression of hepatitis B virus antigen production and replication by wild-type HBV dependently replicating HBV shRNA vectors in vitro and in vivo. Antiviral Research. 134. 117–129. 9 indexed citations
10.
Wang, Ling, Fubiao Kang, Nan Sun, et al.. (2016). The tumor suppressor miR-124 inhibits cell proliferation and invasion by targeting B7-H3 in osteosarcoma. Tumor Biology. 37(11). 14939–14947. 50 indexed citations
11.
12.
13.
Kang, Fubiao, et al.. (2014). Hepatocellular carcinomas promote tumor-associated macrophage M2-polarization via increased B7-H3 expression. Oncology Reports. 33(1). 274–282. 67 indexed citations
14.
Wu, Li‐Ling, Xin Cheng, Baosheng Li, et al.. (2013). Replication-Competent Infectious Hepatitis B Virus Vectors Carrying Substantially Sized Transgenes by Redesigned Viral Polymerase Translation. PLoS ONE. 8(4). e60306–e60306. 19 indexed citations
15.
Wang, Ling, Fubiao Kang, Jie Li, Jing Zhang, & Baoen Shan. (2013). Overexpression of p65 attenuates celecoxib-induced cell death in MDA-MB-231 human breast cancer cell line. Cancer Cell International. 13(1). 23 indexed citations
16.
Liu, Jinxia, Xin Cheng, Dong Li, et al.. (2013). Truncated Active Human Matrix Metalloproteinase-8 Delivered by a Chimeric Adenovirus-Hepatitis B Virus Vector Ameliorates Rat Liver Cirrhosis. PLoS ONE. 8(1). e53392–e53392. 25 indexed citations
17.
Kang, Fubiao, Weiwei Chen, Xinwei Zhang, et al.. (2012). Transient Liver Injury Associated With the Early Recovery of HCV-Specific T-Cell Responses and HCV Rebound in HIV-1/HCV Coinfected Patients Undergoing Highly Active Antiretroviral Therapy. JAIDS Journal of Acquired Immune Deficiency Syndromes. 62(2). 135–142. 9 indexed citations
18.
Xing, Shaojun, Junliang Fu, Zheng Zhang, et al.. (2010). Increased Turnover of FoxP3high Regulatory T Cells Is Associated With Hyperactivation and Disease Progression of Chronic HIV-1 Infection. JAIDS Journal of Acquired Immune Deficiency Syndromes. 54(5). 455–462. 28 indexed citations
19.
Zhang, Zheng, Junliang Fu, Fubiao Kang, et al.. (2009). Progressive CD127 down‐regulation correlates with increased apoptosis of CD8 T cells during chronic HIV‐1 infection. European Journal of Immunology. 39(5). 1425–1434. 19 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pierre Tonnerre Breakdown of academic impact, for papers by Baoyun Fu Breakdown of academic impact, for papers by Yiling Xu Breakdown of academic impact, for papers by Ben Zhao Breakdown of academic impact, for papers by Neru Munshi Breakdown of academic impact, for papers by Christoph M. Ahlers Breakdown of academic impact, for papers by Leal Oburoglu Breakdown of academic impact, for papers by Meng Zhuo Breakdown of academic impact, for papers by Minghua Zhu Breakdown of academic impact, for papers by Mitsuru Sakakibara
Rankless by CCL
2026